Leica Biosystems Bolsters Anatomic Pathology Track Trace Solution Market with Next-Gen Scanner Introduction
Published: 30 Mar 2026
Author: Precedence Research
Leica biosystems has further strengthened its footprint in the Anatomic Pathology Track Trace solutions market with the introduction of their next-generation Aperio GT Elite scanner and Aperio iQC software in March 2026. The new product portfolio is intended for use in high-volume laboratories, ensuring improved workflow efficiency, specimen traceability, and quality assurance. The barcode automation and quality control features of the product are expected to fulfill the increasing need for track trace solutions in pathology laboratories.
Barcode Automation for Efficient Specimen Traceability
The Aperio GT Elite scanner is intended for use in high-throughput slide scanning, ensuring accurate and precise tracking of specimens. The system automatically assigns barcodes to each slide, creating a digital record of all specimens, including their movement and processing. This helps to eliminate errors in slide management, ensuring accurate tracking of each tissue sample through all stages of their lifecycle, from preparation to image analysis. The product is also accompanied by Aperio iQC software, which ensures real-time quality control for laboratories, providing time-stamped logs and quality metrics.
The Anatomic Pathology Track Trace Solution Market size was calculated at USD 951.23 billion in 2025 and is predicted to increase from USD 1,048.26 billion in 2026 to approximately USD 2,512.48 billion by 2035, expanding at a CAGR of 10.20% from 2026 to 2035 as the demand grows for accurate tracking, improved productivity and compliance.
Integrated Digital Workflow Strengthens Track and Trace Capabilities
Unlike traditional track and trace products, which are mainly focused on the tracking of the location of specimens, Leica’s platform is a comprehensive solution as it combines imaging, automation, and digital oversight. The platform is also integrated with Laboratory Information Systems(LIS), which enhances its capability and improves its performance. The use of this platform by laboratories will allow them to streamline their workflow processes while at the same time improving their ability to meet the increasing quality and regulatory requirements for pathology testing.
The launch of the Aperio GT Elite platform also indicates the growing need for digital and AI-based solutions to become integral parts of track and trace processes. The platform has automated data capture, barcode management and AI-based quality control, making a comprehensive solution for laboratories as it digitizes the imaging and enhances the track and trace capability of the platform.
A recent report by Precedence Research highlights that the anatomic pathology track trace solution market is benefiting from barcode/RFID technology, integrated software and real-time analytics.